Defendant
1 case as defendant.
Company overview. 3CX USA Corp. is the U.S. arm of 3CX, a privately held, bootstrapped unified-communications software developer founded by Nick Galea in 2005 and registered in Cyprus in 2006 (3CX Ltd, Nicosia). Its U.S. operations are based in Tampa, Florida, with earlier North American offices in Dallas. The company is not publicly traded and has no disclosed external investors. Third-party trackers (RocketReach, Crustdata) estimate headcount at roughly 150–200 globally and revenue in the low tens of millions of dollars; these figures are estimates and not company-confirmed.
Products / services. 3CX develops the 3CX Phone System, a software-based IP PBX that replaces proprietary hardware phone systems. Running on Windows or Linux, on-premises or in cloud marketplaces (AWS, Azure, Google Cloud), the platform delivers VoIP calling, video conferencing, live chat, SIP trunking, CRM integration, and contact-center features built on open standards (SIP, WebRTC). It targets SMB and enterprise customers.
Patent-litigation posture. 3CX USA Corp. is an operating company that appears purely as a defendant: the tracked database shows zero plaintiff cases and one defendant case. That suit — Lab Technology LLC v. 3CX USA Corp., filed June 16, 2025, in the Southern District of Florida — is a patent-infringement action brought by Lab Technology LLC, a plaintiff that has filed similar VoIP/telephony-patent suits against companies such as Cisco and Lumen. The case targeted U.S. Patent No. 8,483,102 (voice-identity mapping across telephony networks) and was voluntarily dismissed with prejudice in August 2025, roughly 65 days after filing. Note the venue is South Florida rather than the East District of Texas.
Notable context. The suit fits a broader pattern of NPE assertions against VoIP vendors; public docket records also show an earlier 2020 patent suit against 3CX USA Corp. (Tekvoke, LLC) in the Middle District of Florida that falls outside this tracked case set. 3CX itself holds only a small patent portfolio and appears to litigate defensively rather than assert patents. No licensing revenue, settlement terms, or acquisition activity is disclosed in the public record.
Plaintiff voluntarily dismissed 3CX USA Corp. under Rule 41(a)(1)(A)(i); the case was dismissed with prejudice on August 20, 2025, with no fee-shifting, damages, or merits ruling.